Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kane Biotech Inc (TSE:KNE)
TSXV:KNE
Holding TSE:KNE?
Track your performance easily
KNE Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week RangeC$0.05 - C$0.17
Previous CloseC$0.16
Volume32.50K
Average Volume (3M)91.09K
Market Cap
C$20.54M
Enterprise ValueC$31.19M
Total Cash (Recent Filing)C$749.25K
Total Debt (Recent Filing)C$9.25M
Price to Earnings (P/E)―
Beta0.29
Next Earnings
Nov 13, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding131,844,567
10 Day Avg. Volume54,821
30 Day Avg. Volume91,088
Standard Deviation0.13
R-Squared0.04
Alpha0.00664
Financial Highlights & Ratios
Price to Book (P/B)-1.75
Price to Sales (P/S)132.75
Price to Cash Flow (P/CF)-6.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Kane Biotech News
PremiumCompany Announcements
Kane Biotech Breaks into Middle East Market
PremiumCompany Announcements
Kane Biotech Expands revyve™ Gel Product Line
PremiumCompany Announcements
Kane Biotech Enhances revyve™ Wound Care Line
PremiumCompany Announcements
Kane Biotech Gains Key International Quality CertificationOptions Prices
Currently, No data available
---
Ownership Overview
41.46% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
58.54% Public Companies and
Individual Investors
KNE FAQ
What was Kane Biotech Inc’s price range in the past 12 months?
Kane Biotech Inc lowest stock price was C$0.05 and its highest was C$0.17 in the past 12 months.
What is Kane Biotech Inc’s market cap?
Currently, no data Available
When is Kane Biotech Inc’s upcoming earnings report date?
Kane Biotech Inc’s upcoming earnings report date is Nov 13, 2024 which is in 80 days.
How were Kane Biotech Inc’s earnings last quarter?
Currently, no data Available
Is Kane Biotech Inc overvalued?
According to Wall Street analysts Kane Biotech Inc’s price is currently Overvalued.
Does Kane Biotech Inc pay dividends?
Kane Biotech Inc does not currently pay dividends.
What is Kane Biotech Inc’s EPS estimate?
Kane Biotech Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Kane Biotech Inc have?
Kane Biotech Inc has 132,511,570 shares outstanding.
What happened to Kane Biotech Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Kane Biotech Inc?
Currently, no hedge funds are holding shares in TSE:KNE
---
Kane Biotech Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Insider Transactions
Bought Shares
Worth C$68.5K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
93.75%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
6.10%
Trailing 12-Months
Company Description
Kane Biotech Inc
Kane Biotech Inc is a Canada based biotechnology company engaged in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms. The company's human health product is DispersinB and animal health products include bluestem oral care, STRIX NB, and Alosera. In addition, the company also provides technologies for industrial applications such as medical device coating and hard surface disinfectant.
---
Technical Analysis
---